GLP-1 RA werden heute auch bei cv Erkrankungen und bei der Adipositas erfolgreich eingesetzt (Abb
Nov 1 2023;12(11)doi:10.1530/ec-23-0257 Wilding JPH, Batterham RL, Davies M, et al
10.1016/j.cgh.2023.06.004 92 ZhangN.LiuC.ZhangY.XuD.GuiL.LuY.et al (2021)
SIBO Breath Testing Breath testing may be used in selected patients, but sulfur odor alone is not enough
However, the agencies analyses at the time were hindered by the small number of reported instances of suicidal thoughts and behaviors, resulting in what the FDA on Monday called considerable uncertainty in the risk estimate. For more clarity on the matter, the agency conducted a meta-analysis of different GLP-1 trials, encompassing more than 90 studies and nearly 108,000 patients
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy